Macro Finance
EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen
Bloomberg Markets·October 21, 2026·1 min read
EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion), according to people familiar with the matter. The acquisition would end years of takeover speculation involving the European molecular testing company, marking a significant consolidation in the diagnostics sector.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.